The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol

Chun-Jung Cho1,2, Ching-Wei Yang3, Chia-Lun Wu2

  • 1Graduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei 114, Taiwan, R.O.C.

Oncology Letters
|December 7, 2019
PubMed

Insights

Phytochemicals like curcumin and resveratrol can reverse gemcitabine (GCB) resistance in bladder cancer cells. These compounds enhance GCB

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Gemcitabine (GCB) is a key chemotherapy for bladder cancer, but drug resistance limits its efficacy.
  • Phytochemicals are being investigated for their potential to overcome chemotherapy resistance in cancer.
  • Understanding the molecular mechanisms of GCB resistance is crucial for developing effective treatments.

Purpose of the Study:

  • To evaluate the potential of phytochemicals, specifically resveratrol and curcumin, to reverse gemcitabine resistance in bladder cancer cells.
  • To investigate the effects of these phytochemicals on drug resistance markers and cellular behavior.

Main Methods:

  • Established gemcitabine-resistant T24 bladder cancer cells (T24-GCB).
  • Assessed drug resistance using MTT assays and measured cross-resistance to other chemotherapeutics.
  • Analyzed gene and protein expression of ATP-binding cassette (ABC) transporters, thymidine kinases (TKs), and poly (ADP-ribose) polymerase (PARP) using RT-qPCR and Western blotting.
  • Evaluated the impact of curcumin and resveratrol, alone and with GCB, on cell viability and migration.

Main Results:

  • T24-GCB cells exhibited significantly increased resistance to GCB (18.75-fold higher ID50) and cross-resistance to mitomycin C and paclitaxel.
  • Elevated ABCC2 expression and decreased expression of ABCB1, ABCG2, deoxycytidine kinase (DCK), TK1, and TK2 were observed in T24-GCB cells.
  • Curcumin and resveratrol, alone or combined with GCB, demonstrated additive cytotoxic effects and reduced cell migration.
  • Co-treatment increased cleaved-PARP expression, indicating apoptosis, without altering ABCC2 and DCK, TK1, TK2 expression levels.

Conclusions:

  • Resveratrol and curcumin can effectively reverse gemcitabine resistance in bladder cancer cells.
  • These phytochemicals enhance GCB cytotoxicity and reduce cell migration, offering a potential strategy to improve bladder cancer treatment outcomes.
  • The observed effects are associated with PARP activation, suggesting a role in overcoming drug resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K